6:08 AM ET
8-K
Leadership Change
Verastem Leadership Change
Verastem Oncology announced that Daniel W. Paterson will retire as President and CEO effective January 1, 2027, and will be succeeded by Michael P. Bailey. Mr. Paterson will remain on the Board of Directors and serve as an advisor, while Mr. Bailey, an existing director with over 30 years of industry experience, will lead the company's next phase of commercial growth.